Responsive nanomedicines enhanced by or enhancing physical modalities to treat solid cancer tumors: Preclinical and clinical evidence of safety and efficacy
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 181, 114075
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- A Mathematical Model of the Enhanced Permeability and Retention Effect for Liposome Transport in Solid TumorsPLOS ONE, 2013
- Evidence for a new mechanism behind HIFU-triggered release from liposomesJournal of Controlled Release, 2013
- Ionizing radiation increases systemic nanoparticle tumor accumulationNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of RadiotherapyACS Nano, 2011
- Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV IrradiationsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Radiation-Guided Drug Delivery to Mouse Models of Lung CancerClinical Cancer Research, 2010
- Targeted Nanoparticles That Deliver a Sustained, Specific Release of Paclitaxel to Irradiated TumorsCancer Research, 2010
- Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neckHead & Neck, 2009
- A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancerLung Cancer, 2004
- Integrin-mediated targeting of drug delivery to irradiated tumor blood vesselsCancer Cell, 2003